Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Docosahexaenoic Acids | 4 | 2023 | 905 | 1.020 |
Why?
|
| Hepatectomy | 1 | 2024 | 559 | 0.730 |
Why?
|
| Fatty Acids | 1 | 2024 | 1803 | 0.520 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 1931 | 0.450 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 2294 | 0.390 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 4314 | 0.360 |
Why?
|
| Neoplasms | 5 | 2024 | 21986 | 0.360 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1895 | 0.340 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 13597 | 0.310 |
Why?
|
| Lipids | 1 | 2018 | 3326 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2796 | 0.280 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2022 | 257 | 0.180 |
Why?
|
| Common Bile Duct | 1 | 2019 | 106 | 0.170 |
Why?
|
| Choledocholithiasis | 1 | 2019 | 49 | 0.160 |
Why?
|
| Inflammation Mediators | 2 | 2018 | 1879 | 0.160 |
Why?
|
| Ketorolac | 1 | 2019 | 94 | 0.160 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2019 | 231 | 0.150 |
Why?
|
| Hemangiosarcoma | 1 | 2019 | 216 | 0.140 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2019 | 505 | 0.140 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 188 | 0.140 |
Why?
|
| Phagocytosis | 2 | 2019 | 1532 | 0.120 |
Why?
|
| Melanoma, Experimental | 1 | 2017 | 559 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1228 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1557 | 0.110 |
Why?
|
| Macrophages | 3 | 2019 | 5732 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3069 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 282 | 0.100 |
Why?
|
| Survival Rate | 2 | 2024 | 12684 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2017 | 1886 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2019 | 2246 | 0.090 |
Why?
|
| Lymphoma | 1 | 2019 | 1900 | 0.090 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2014 | 538 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3573 | 0.080 |
Why?
|
| Simian immunodeficiency virus | 1 | 2014 | 805 | 0.080 |
Why?
|
| Pain | 1 | 2023 | 5063 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2325 | 0.070 |
Why?
|
| Aspirin | 1 | 2019 | 3128 | 0.070 |
Why?
|
| Myocarditis | 1 | 2014 | 765 | 0.070 |
Why?
|
| Cytokines | 2 | 2019 | 7336 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14345 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 10709 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9514 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 2818 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9245 | 0.060 |
Why?
|
| Prognosis | 1 | 2024 | 29488 | 0.060 |
Why?
|
| Humans | 10 | 2024 | 757566 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2014 | 3996 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8600 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18114 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10405 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10167 | 0.050 |
Why?
|
| Myocardium | 1 | 2014 | 4690 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16881 | 0.050 |
Why?
|
| Animals | 5 | 2019 | 167718 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2023 | 482 | 0.040 |
Why?
|
| Plasminogen Inactivators | 1 | 2019 | 37 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6840 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 829 | 0.040 |
Why?
|
| Ifosfamide | 1 | 2019 | 232 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4886 | 0.040 |
Why?
|
| Prostaglandins | 1 | 2019 | 398 | 0.040 |
Why?
|
| Eicosanoids | 1 | 2019 | 278 | 0.040 |
Why?
|
| Mice | 3 | 2019 | 81066 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 604 | 0.030 |
Why?
|
| Lipoxins | 1 | 2019 | 418 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 540 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 20992 | 0.030 |
Why?
|
| Chemokines | 1 | 2019 | 960 | 0.030 |
Why?
|
| Viral Fusion Proteins | 1 | 2014 | 99 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1073 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2014 | 311 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2019 | 2211 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2014 | 602 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2014 | 552 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3839 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6204 | 0.020 |
Why?
|
| Metabolomics | 1 | 2019 | 1629 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 7796 | 0.020 |
Why?
|
| Sex Factors | 1 | 2022 | 10495 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2014 | 2316 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8512 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6757 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10075 | 0.020 |
Why?
|
| Fibrosis | 1 | 2014 | 2038 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 4407 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2014 | 2837 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2019 | 79984 | 0.010 |
Why?
|
| Viral Load | 1 | 2014 | 3321 | 0.010 |
Why?
|
| Monocytes | 1 | 2014 | 2568 | 0.010 |
Why?
|
| Female | 5 | 2023 | 389943 | 0.010 |
Why?
|
| Liver | 1 | 2019 | 7502 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 64242 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2014 | 3806 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21990 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4550 | 0.010 |
Why?
|
| Male | 3 | 2019 | 358180 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 42045 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 219192 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 58558 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 167890 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 219725 | 0.000 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_